Role of NF-κB in the skeleton | Cell Research
NF-κB control of T cell development | Nature Immunology
Frontiers | Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
Genes | Free Full-Text | Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer
Frontiers | The Th17 Pathway in Vascular Inflammation: Culprit or Consort?
NF-κB c-Rel Dictates the Inflammatory Threshold by Acting as a Transcriptional Repressor - ScienceDirect
IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation - ScienceDirect
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
Genes | Free Full-Text | NF-kappaB: Two Sides of the Same Coin
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology: Trends in Molecular Medicine
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
Frontiers | Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis
Pathogens | Free Full-Text | The Double Game Played by Th17 Cells in Infection: Host Defense and Immunopathology
Interactome Networks of FOSL1 and FOSL2 in Human Th17 Cells | ACS Omega
IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer
SMAC mimetics promote NIK-dependent inhibition of CD4+ TH17 cell differentiation | Science Signaling
Frontiers | Modeling the Th17 and Tregs Paradigm: Implications for Cancer Immunotherapy
Frontiers | The Yin and Yang of IL-17 in Systemic Sclerosis
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases
The PRAK-NRF2 axis promotes the differentiation of Th17 cells by mediating the redox homeostasis and glycolysis | PNAS
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology: Trends in Molecular Medicine
